These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 84392)

  • 1. Liver antigens detected by liver antinucleolar antibodies.
    Busch RK; Reddy RC; Henning DH; Busch H
    Proc Soc Exp Biol Med; 1979 Feb; 160(2):185-91. PubMed ID: 84392
    [No Abstract]   [Full Text] [Related]  

  • 2. Characterization of nucleolar antigens of normal rat liver, regenerating rat liver, and Novikoff ascites hepatoma cells following in vitro translation of polyadenylic acid-containing messenger RNA.
    Satoh K; Busch H
    Cancer Res; 1983 May; 43(5):2143-9. PubMed ID: 6831440
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of polysomes synthesizing Novikoff hepatoma nucleolar antigens.
    Reiners JJ; Davis FM; Busch H
    Cancer Res; 1980 May; 40(5):1367-71. PubMed ID: 7370978
    [No Abstract]   [Full Text] [Related]  

  • 4. Differences in nucleolar antigens of rat liver and Novikoff hepatoma ascites cells.
    Davis FM; Busch RK; Yeoman LC; Busch H
    Cancer Res; 1978 Jul; 38(7):1906-15. PubMed ID: 77722
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Purification and partial characterization of nucleolar antigen-1 of the Novikoff hepatoma.
    Marashi F; Davis FM; Busch RK; Savage HE; Busch H
    Cancer Res; 1979 Jan; 39(1):59-66. PubMed ID: 761199
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of murine hepatoma BW7756. II. Comparison of adult, fetal, and neoplastic liver soluble antigens.
    Mizejewski GJ; Chang G
    Neoplasma; 1978; 25(5):549-58. PubMed ID: 84344
    [No Abstract]   [Full Text] [Related]  

  • 7. Results of a preliminary "blind" study on the presence of the human tumor nucleolar antigen in breast carcinomas, benign breast tumors, and normal breast tissues.
    Busch H; Busch RK; Chan PK; Isenberg W; Weigand R; Russo J; Furmanski P
    Clin Immunol Immunopathol; 1981 Feb; 18(2):155-67. PubMed ID: 7008990
    [No Abstract]   [Full Text] [Related]  

  • 8. Rabbit antibodies to nucleoli of Novikoff hepatoma and normal liver of the rat.
    Busch RK; Daskal I; Spohn WH; Kellermayer M; Busch H
    Cancer Res; 1974 Sep; 34(9):2362-7. PubMed ID: 4367290
    [No Abstract]   [Full Text] [Related]  

  • 9. Antinucleolar antibodies in the sera of patients with malignant melanoma.
    McBride CM; Bowen JM; Dmochowski LL
    Surg Forum; 1972; 23(0):92-3. PubMed ID: 4601070
    [No Abstract]   [Full Text] [Related]  

  • 10. Masking of nontumorous antigens for development of human tumor nucleolar antibodies with improved specificity.
    Freeman JW; Busch RK; Ross BE; Busch H
    Cancer Res; 1985 Nov; 45(11 Pt 2):5637-42. PubMed ID: 3902213
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Localization of phosphoprotein C23 in nucleoli by immunological methods.
    Olson MO; Guetzow K; Busch H
    Exp Cell Res; 1981 Oct; 135(2):259-65. PubMed ID: 6796426
    [No Abstract]   [Full Text] [Related]  

  • 12. Novel nucleolar antigens in autoimmune disease.
    Busch H; Busch RK; Black A; Chan PK; Chatterjee A; Durban E; Freeman J; Ochs R; Reichlin M; Tan EM
    J Rheumatol Suppl; 1987 Jun; 14 Suppl 13():70-7. PubMed ID: 2441047
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Differences in the antigenic structure of chromatin from the liver and hepatoma cells in the rat].
    Nanazashvili MG; Ermekova VM; Serykh MM; Umanskiĭ SR
    Eksp Onkol; 1984; 6(3):38-42. PubMed ID: 6209092
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Murine monoclonal antibodies against "liver specific lipoprotein" (LSP) defining three antigenic sites which differ in tissue- and species-distribution and subcellular location.
    Kenna JG; Major GN; Lambert KJ; McFarlane IG; Williams R
    Liver; 1985 Feb; 5(1):13-20. PubMed ID: 2580210
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Intranuclear localization of hepatoma chromatin antigens not detected in liver chromatin].
    Nanazashvili MG; Serykh MM; Ermekova VM
    Eksp Onkol; 1984; 6(5):39-42. PubMed ID: 6510342
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Experimental liver membrane antibodies (LMA) and antibodies against "liver specific protein (LSP)"--a comparative in vitro study.
    Stemerowicz R; Möller B; Jahn HU; Schwämmle K; Berg PA; Hopf U
    J Clin Lab Immunol; 1990 May; 32(1):13-9. PubMed ID: 1967032
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumour antigens and alloantigens. I. Relation of a rat tumour-specific antigen with normal alloantigens of the host strain.
    Bowen JG; Baldwin RW
    Int J Cancer; 1979 Jun; 23(6):826-32. PubMed ID: 89101
    [No Abstract]   [Full Text] [Related]  

  • 18. The tolerogenicity and biological activity of subcellular antigen fractions.
    Cerilli J; Lang RW; Hattan D
    J Surg Res; 1974 Jun; 16(6):565-8. PubMed ID: 4599464
    [No Abstract]   [Full Text] [Related]  

  • 19. Nucleolar localization of the PM-Scl antigen.
    Targoff IN; Reichlin M
    Arthritis Rheum; 1985 Feb; 28(2):226-30. PubMed ID: 3918546
    [No Abstract]   [Full Text] [Related]  

  • 20. An antigenic portrait of the liver during carcinogenesis.
    Hixson DC; Faris RA; Thompson NL
    Pathobiology; 1990; 58(2):65-77. PubMed ID: 2193646
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.